AREDS2 supplementation
AREDS2 supplementation has been studied in 2 papers since 2026: none in people yet, 2 reviews; 2 in the past year. No study of it in people or animals has been published yet. The newest paper, Oct 19, 2026: “The Environmental Exposome and Age-Related Macular Degeneration: Oxidative Stress as a Molecular Link”.
2 papers study it2 findingsUpdated
1 new paper in 30 daysSee all 2 papers on AREDS2 supplementation
What did studies of AREDS2 supplementation find?
1Studies of AREDS2 supplementation measured one outcome, lung cancer.
Lung cancer
no changein humans1
1 study
Lung cancer
no changein humans1
AREDS2 supplementation showed no clear effect on lung cancer in smokers.
“without increasing the risk of lung cancer in smokers”
Reviewin smokers
Cermin Dunia Kedokteran
What is AREDS2 supplementation linked with?
1Studies link AREDS2 supplementation with age-related macular degeneration progression.
Age-related macular degeneration progression
downin humans1−18% risk
1 study
Age-related macular degeneration progression
downin humans1−18% risk
AREDS2 supplementation lowers the risk of age-related macular degeneration progression in humans (18% reduction in risk).
“has been shown to reduce the risk of AMD progression by 18%”
Reviewreplacing beta-carotene with lutein and zeaxanthin
Cermin Dunia Kedokteran